Activest Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Hold
708
0.03% 152
2026
Q1
$120K Buy
708
+234
+49% +$40K 0.02% 206
2025
Q4
$80K Hold
474
0.01% 245
2025
Q3
$68.5K Sell
474
-3
-0.6% -$409 0.01% 227
2025
Q2
$60.3K Hold
477
0.01% 188
2025
Q1
$61K Sell
477
-140
-23% -$19K 0.02% 176
2024
Q4
$81.6K Sell
617
-235
-28% -$33K 0.02% 140
2024
Q3
$124K Sell
852
-467
-35% -$67.6K 0.04% 106
2024
Q2
$181K Buy
1,319
+845
+178% +$113K 0.06% 87
2024
Q1
$65K Sell
474
-339
-42% -$46.3K 0.03% 100
2023
Q4
$110K Buy
813
+339
+72% +$41.4K 0.06% 58
2023
Q3
$58K Buy
+474
New +$60.3K 0.04% 84
2023
Q2
Sell
-474
Closed -$60.8K 340
2023
Q1
$60.8K Buy
+474
New +$62K 0.04% 77
2022
Q3
Sell
-474
Closed -$56K 515
2022
Q2
$56K Sell
474
-899
-65% -$107K 0.04% 90
2022
Q1
$179K Hold
1,373
0.12% 51
2021
Q4
$210K Sell
1,373
-158
-10% -$24.5K 0.13% 54
2021
Q3
$248K Buy
1,531
+245
+19% +$41.2K 0.17% 52
2021
Q2
$210K Sell
1,286
-286
-18% -$44.1K 0.16% 47
2021
Q1
$237K Buy
+1,572
New +$250K 0.19% 48

Other funds holding IBB

Activest Wealth Management's IBB Position: Q2 2026 in Review

Activest Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 708 shares worth $135K. The position accounts for 0.03% of the portfolio, ranked #152.

Activest Wealth Management first reported a position in IBB in Q1 2021 and has held it in 19 quarters since. The position peaked at $248K in Q3 2021. 347 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Activest Wealth Management held 708 shares of iShares Biotechnology ETF worth $135K as of Q2 2026.
  • Activest Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.03% of Activest Wealth Management's portfolio in Q2 2026, its #152 holding.
  • Activest Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 19 quarters since.
  • Activest Wealth Management's iShares Biotechnology ETF position peaked at $248K in Q3 2021.
  • 347 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.